According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, a treatment strategy guided by ultrasound information use does not appear to provide better treatment decisions in patients with early rheumatoid arthritis.
A new study found that very few serious infections were seen in children born to mothers with chronic inflammatory diseases who used non-TNFi biologics or tofacitinib during pregnancy compared to children not exposed to these drugs and children exposed to TNFi biologics in utero. These findings are being presented this week at the 2019 ACR/ARP Annual Meeting (Abstract #1901).
Research presented at the 2019 ACR/ARP Annual Meeting found that a six-week treatment with low-dose oral prednisolone substantially improves pain and decreases signs of inflammation in patients with painful hand osteoarthritis.
According to new research findings presented this week at the 2019 ACR/ARP Annual Meeting, supportive laboratory assays to diagnose lupus, specifically the antinuclear antibody (ANA) test, are less often offered in developing nations due to a relative lack of resources.
The deadline for complimentary press registration for the 2019 ACR/ARP Annual Meeting is Wednesday, Oct. 23.
Americans living with rheumatic disease face significant healthcare challenges, according to a national patient survey released this week by the American College of Rheumatology and its Simple Tasks™ public awareness campaign.
The American College of Rheumatology (ACR), along with 369 other leading patient, physician, and healthcare professional organizations, sent a letter to Congress urging passage of the Improving Seniors' Timely Access to Care Act of 2019 (H.R. 3107), a bipartisan bill to protect Medicare Advantage beneficiaries from prior authorization requirements that needlessly delay or deny access to medically necessary care.
Physicians, health professionals and rheumatology patients gathered on Capitol Hill this week to urge lawmakers to support the Safe Step Act, Empower for Health Act, and the REDI Act during ACR's annual Advocates for Arthritis event.
In recent years, several states have enacted legislation to hold pharmacy benefit managers accountable and crack down on secretive practices that drive up costs for consumers.
World champion tennis player, Venus Williams, is teaming up with the American College of Rheumatology (ACR) to share important information about rheumatic diseases in a new public service announcement (PSA) set to air nationwide this fall.
Today, the American College of Rheumatology (ACR), in partnership with the Spondylitis Association of America (SAA) and the Spondyloarthritis Research and Treatment Network (SPARTAN), released the 2019 Update of the Recommendations for the Treatment of Ankylosing Spondylitis (AS) and Nonradiographic Axial Spondyloarthritis (nr-axSpA).
The American College of Rheumatology (ACR) today applauded the Centers for Medicare & Medicaid Services (CMS) for including proposed reimbursement changes to evaluation and management (E/M) codes in its CY 2020 Physician Fee Schedule Proposed Rule.
The American College of Rheumatology (ACR) and the Association for Rheumatology Professionals (ARP) welcomes members of the press to write about research presented at the 2019 ACR/ARP Annual Meeting.
In August 2018, the CMS announced that Medicare Advantage (MA) plans would be allowed to utilize step therapy for Part B drugs. The American College of Rheumatology (ACR) expressed strong concerns about this proposal. The rheumatology community received some good news in this week’s final rule from CMS, which makes changes to the original proposal and addresses several of our community’s recommendations.
Today, the American College of Rheumatology (ACR), in partnership with the Arthritis Foundation (AF), released two guidelines on juvenile idiopathic arthritis (JIA). One guideline aims to provide therapeutic approaches for non-systemic polyarthritis, sacroilitis and enthesitis; and the other focuses on the screening, monitoring and treatment of JIA with associated uveitis.
The American College of Rheumatology today praised Representative Raul Ruiz, MD (D-CA) and Representative Brad Wenstrup, MD (R-OH) for introducing the “Safe Step Act” (H.R. 2279). If enacted, H.R. 2279 would place reasonable parameters around the use of step therapy among employer-sponsored health plans.
The American College of Rheumatology and 24 other patient and provider organizations are calling on CMS to immediately add step therapy safeguards to the agency's proposal allowing Medicare Advantage plans to utilize step therapy for Part B drugs.
The American College of Rheumatology (ACR) has released new drug pricing and step therapy position statements that they hope legislators will consider as they continue to explore policy and regulatory options to make drugs more affordable and accessible.
The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented at the State-of-the-Art Clinical Symposium (SOTA) in Chicago, IL, on April 5-7.
In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) expressed its continuing concern with a recent CMS policy allowing Medicare Advantage (MA) plans to utilize step therapy for Part B drugs. In the comment letter, rheumatology leaders urged the agency to establish safeguards to protect beneficiaries from potential harm.
– In comments submitted to the Centers for Medicare and Medicaid Services (CMS), the American College of Rheumatology (ACR) urged the agency to proceed with caution when considering the International Pricing Index (IPI) drug pricing model, which was announced in an Advance Notice of Proposed Rulemaking in October.
The American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF) have released a joint treatment guideline for psoriatic arthritis (PsA) that provides evidence-based pharmacologic and non-pharmacologic recommendations on caring for treatment-naïve patients with active PsA and patients who continue to have active PsA despite treatment.
The American College of Rheumatology (ACR) welcomes members of the press to write about rheumatology research presented the Winter Rheumatology Symposium in Snowmass Village, CO on January 26 to February 1, 2019.
The American College of Rheumatology (ACR) will present the draft of a new clinical practice guideline for the management of reproductive health in patients with rheumatic diseases during a session at the 2018 ACR/ARHP Annual Meeting this week at McCormick Place in Chicago. The Reproductive Health in Rheumatic Diseases Guideline is the first evidence-based, clinical practice guideline related to the management of all reproductive health issues for patients across the spectrum of rheumatic diseases.
Genetic risk scoring may be a clinically useful way to help identify ankylosing spondylitis far earlier, and at a lower cost, than current testing methods, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
According to new research findings presented this week at the ACR/ARHP Annual Meeting, IgG antiphospholipid antibody positivity and myocardial infarction (MI) – also known as a heart attack – are strongly and independently associated, suggesting it may be an important, often-overlooked risk factor for heart attack in the general population.
Detailed analysis of bone marrow edema and their anatomical location can help rheumatologists differentiate patients with axial spondyloarthritis from those with similar, more common conditions according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
A combined scan of positron emission tomography (PET) and computed tomography (CT) has good diagnostic accuracy compared with temporal artery biopsy in patients newly suspected of having giant cell arteritis, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting (Abstract #L15).
Failure to reach a serum urate target of 6 mg/dl independently predicts mortality in patients with gout, and a treat-to-target gout control strategy should be considered as a way to improve a patient’s chance of survival, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting
Vascular ultrasound is sensitive enough to use as a first-line imaging test in patients suspect to have giant cell arteritis, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Rheumatoid arthritis patients who achieve low disease activity or remission may successfully taper their biologics, saving costs as a result, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Patients with high-risk systemic lupus erythematosus (SLE) may have a decreased risk of hospitalization and a shorter length of stay when their access to rheumatologic care is improved, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Patients with knee osteoarthritis who walk at a moderate-to-vigorous intensity may lower their risk of total knee arthroplasty, or joint replacement surgery, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Hematopoietic stem cell transplantation showed benefit in a subset of patients with systemic sclerosis who tend not to improve on immunosuppressive therapies like mycophenolate mofetil, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Using a culturally competent, well-designed online resource helps increase awareness of systemic lupus erythematosus (SLE) and its symptoms in at-risk patient populations, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting .
New research at the 2018 ACR/ARHP Annual Meeting builds on current evidence that hematopoietic stem cell transplantation can significantly improve long-term outcomes for patients with severe scleroderma when compared to use of conventional treatment with cyclophosphamide.
Recurrent lupus nephritis, a severe complication for patients with systemic lupus erythematosus (SLE) with end-stage renal disease who undergo kidney transplant, is happening less often now compared to the past. This positive trend is likely due to improvements in the immunosuppression regimen these patients now receive, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Over the past two decades, maternal and fetal mortality, along with important clinical outcomes, have improved in pregnancies of women with systemic lupus erythematosus (SLE), according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Patient-reported outcomes and input about treatment satisfaction collected via tablet computers in the clinic can enhance a treat-to-target approach for managing rheumatoid arthritis, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Patients with meniscal tears and osteoarthritic changes in their knee generally experience substantial pain relief over five years whether they receive physical therapy or arthroscopic partial meniscectomy, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Women who experienced physical or emotional abuse in childhood have a significantly increased risk of developing systemic lupus erythematosus (SLE) as adults, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
Nearly half of adult rheumatoid arthritis patients in a national registry did not change their current treatment over the next year to reach a “treat-to-target” goal for low disease activity, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
High-dose influenza vaccination substantially improves immune responses against influenza in adults with seropositive rheumatoid arthritis, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting .
Depression, anxiety, and physical impairment are more prevalent in children with arthritis who have high adverse childhood experiences, according to new research findings presented this week at the 2018 ACR/ARHP Annual Meeting.
The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) will present advanced drafts of two updated classification criteria for giant cell arteritis and Takayasu’s arteritis, the two major categories of large-vessel vasculitis, during a session at the 2018 ACR/ARHP Annual Meeting this week at McCormick Place in Chicago.
The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) will present a draft of the Classification Criteria for IgG4-Related Disease, the first classification criteria developed for this recently recognized disease, during a session at the 2018 ACR/ARHP Annual Meeting this week at McCormick Place in Chicago. The classification criteria are currently under review by the ACR and EULAR for endorsement.
The American College of Rheumatology (ACR) announced the 2018 recipients of its Master of the ACR designation, Awards of Distinction, and Distinguished Fellow Award honors during the opening lecture of the 2018 ACR/ARHP Annual Meeting in Chicago. These recognitions are given annually to members who exhibit outstanding contributions to the ACR and the field of rheumatology.
Members of the press are invited to submit their request for a press pass to the 2018 ACR/ARHP Annual Meeting by Friday, Oct. 12.
In comments submitted to the Centers for Medicare and Medicaid Services (CMS) regarding the 2019 Medicare Physician Fee Schedule proposed rule, the American College of Rheumatology (ACR) cautioned policymakers against implementing a proposal to reduce physician reimbursement for evaluation and management (E/M) services, arguing that doing so could severely compromise patient access to care and further exacerbate the growing rheumatology workforce shortage.
The American College of Rheumatology (ACR) today released the Rheumatic Disease Report Card: Raising the Grade on Rheumatology Care in America, a first-of-its-kind report that evaluates just how difficult it can be to live well with a rheumatic disease in the United States.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right